Otogenetics Corporation
UEI: N8VSYHPYNLB7
Overview
Awardee Type
Parent
Federal Capability Statement
Otogenetics is specialized in clinical genetic and molecular testing, and in test development and validation.
Keywords
Next Generation, Sequencing, NGS, RNA, RNA-Seq, Exome, Methylation, Epigenetic, Custom Targeted, DNA, Whole Genome, WGS, WES, HiSeq, MiSeq, Illumina, SureSelect, NimbleGen, Cancer, Mitochondria, Cardiac Myopathy, miRNA, smRNA, Metagenomics, CNV analysis
SBA Special Equipment
High capacity sequencers, Sanger Sequencers, Robotic liquid handlers
Headquarters
Atlanta, GA
United States
United States
Federal recipient
OTOGENETICS CORPORATION
(UEI N8VSYHPYNLB7)
is headquartered in Atlanta GA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in October 2007 and
federally registered in
November 2007.
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI TN78B1GJRWR8 CAGE 4X2G4 instead.
Legal Name
OTOGENETICS CORPORATION
UEI
TN78B1GJRWR8
CAGE Code
4X2G4
SBA Certifications
None
Self Certifications
Asian-Pacific American Owned
Minority Owned Business
Self-Certified Small Disadvantaged Business
Woman Owned Business
Woman Owned Small Business
Minority Owned Business
Self-Certified Small Disadvantaged Business
Woman Owned Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 28, 2007
Initial Registration
Nov. 19, 2007
Last Registration
July 18, 2024
Registration Activation
July 18, 2024
Registration Expiration
July 16, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
GA
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes